MONTANOVA CAPITAL, LLC — 13F Holdings & Portfolio

CIK 1569064 · latest 13F-HR filed 2026-08-14

MONTANOVA CAPITAL, LLC manages $5.47B in 13F-reported U.S. long-equity assets across 96 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are SPY (12.97%), MANE (9.37%), ARQT (5.96%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 21 new positions, exited 14, added to 41, and trimmed 19.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$5.47B

Long-equity book

Holdings

96

Distinct positions

Period

2026-06-30

Filed 2026-08-14

Q/Q Activity

+21 / −14 / ↑41 / ↓19

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Firm Profile & Key People
Name Title / Status Ownership Type

Quarter-over-quarter changes

Share-count changes vs the prior 13F.

Top Adds (vs prior quarter)

  • VERADERMICS INC$249.3M +94.7%
  • ADVANCED MICRO DEVICES INC$97.1M +185.6%
  • LEGEND BIOTECH CORP$67.0M +48.9%
  • BIOHAVEN LTD$66.0M +75.9%
  • ARRIVENT BIOPHARMA INC$55.3M +54.5%
Show all 41 →

Top Trims

  • COMPASS THERAPEUTICS INC-$44.8M -59.2%
  • MINERALYS THERAPEUTICS INC-$37.0M -88.7%
  • FULCRUM THERAPEUTICS INC-$36.9M -73.2%
  • US FOODS HLDG CORP-$35.8M -98.1%
  • PERFORMANCE FOOD GROUP CO-$31.5M -95.0%
Show all 19 →

New Positions

  • AVALYN PHARMACEUTICALS INC$82.4M
  • HUT 8 CORP$77.3M
  • AMPHENOL CORP$47.5M
  • ROUNDHILL ETF TRUST$44.5M
  • CEREBRAS SYSTEMS INC$38.0M
Show all 21 →

Exited Positions

  • APELLIS PHARMACEUTICALS INC$141.5M
  • KALVISTA PHARMACEUTICALS INC$96.0M
  • ERASCA INC$55.6M
  • LIFE TIME GROUP HOLDINGS INC$13.7M
  • WINGSTOP INC$9.2M
Show all 14 →
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 STATE STR SPDR S&P 500 ETF T Put SPY 78462F103 $709.4M 12.97% 950,000 SH
2 VERADERMICS INC MANE 922967104 $512.5M 9.37% 4,168,970 SH
3 ARCUTIS BIOTHERAPEUTICS INC ARQT 03969K108 $326.1M 5.96% 12,437,000 SH
4 LEGEND BIOTECH CORP LEGN 52490G102 $204.2M 3.73% 7,070,000 SH
5 PALVELLA THERAPEUTICS INC NE PVLA 697947109 $173.5M 3.17% 1,135,406 SH
6 ARRIVENT BIOPHARMA INC AVBP 04272N102 $156.9M 2.87% 4,515,531 SH
7 BENITEC BIOPHARMA INC BNTC 08205P209 $154.5M 2.83% 11,548,351 SH
8 BIOHAVEN LTD BHVN G1110E107 $153.1M 2.80% 10,286,937 SH
9 ADVANCED MICRO DEVICES INC AMD 007903107 $149.4M 2.73% 257,240 SH
10 ARCUS BIOSCIENCES INC RCUS 03969F109 $147.3M 2.69% 4,776,423 SH
11 TAIWAN SEMICONDUCTOR MANUFAC TSM 874039100 $145.5M 2.66% 304,627 SH
12 NVIDIA CORPORATION NVDA 67066G104 $144.2M 2.64% 720,609 SH
13 EYEPOINT INC EYPT 30233G209 $118.6M 2.17% 8,296,375 SH
14 SYSCO CORP SYY 871829107 $118.0M 2.16% 1,411,550 SH
15 GE AEROSPACE GE 369604301 $116.0M 2.12% 310,262 SH
16 IMMATICS N.V IMTX N44445109 $113.4M 2.07% 11,190,129 SH
17 MGM RESORTS INTERNATIONAL MGM 552953101 $111.2M 2.03% 2,325,360 SH
18 META PLATFORMS INC META 30303M102 $99.0M 1.81% 175,807 SH
19 CAPRICOR THERAPEUTICS INC CAPR 14070B309 $98.6M 1.80% 4,092,784 SH
20 KURA ONCOLOGY INC KURA 50127T109 $94.1M 1.72% 8,575,422 SH
21 MONTE ROSA THERAPEUTICS INC GLUE 61225M102 $85.9M 1.57% 3,549,539 SH
22 AVALYN PHARMACEUTICALS INC AVLN 05348Y105 $82.4M 1.51% 2,503,109 SH
23 HOME DEPOT INC HD 437076102 $79.7M 1.46% 226,053 SH
24 HUT 8 CORP HUT 44812J104 $77.3M 1.41% 670,000 SH
25 CAPITAL ONE FINL CORP COF 14040H105 $66.8M 1.22% 333,098 SH
26 VULCAN MATLS CO VMC 929160109 $63.4M 1.16% 214,978 SH
27 FERGUSON ENTERPRISES INC FERG 31488V107 $58.6M 1.07% 246,758 SH
28 ZURA BIO LTD ZURA G9TY5A101 $55.7M 1.02% 9,443,001 SH
29 INFLARX NV IFRX N44821101 $51.4M 0.94% 22,933,910 SH
30 AURA BIOSCIENCES INC AURA 05153U107 $51.2M 0.94% 7,206,217 SH
31 FAETH THERAPEUTICS INC FTH 81728A207 $50.5M 0.92% 2,020,103 SH
32 ADVISORSHARES TR MSOS 00768Y453 $49.5M 0.90% 9,738,524 SH
33 AMAZON COM INC AMZN 023135106 $48.8M 0.89% 204,860 SH
34 REPLIMUNE GROUP INC REPL 76029N106 $48.6M 0.89% 4,389,836 SH
35 AMPHENOL CORP APH 032095101 $47.5M 0.87% 269,300 SH
36 SPOTIFY TECHNOLOGY S A SPOT L8681T102 $46.7M 0.85% 101,800 SH
37 CONTINEUM THERAPEUTICS INC CTNM 21217B100 $46.6M 0.85% 2,841,334 SH
38 APOLLO GLOBAL MGMT INC APO 03769M106 $45.3M 0.83% 383,300 SH
39 BANK OF AMER CORP BAC 060505104 $45.0M 0.82% 789,720 SH
40 ROUNDHILL ETF TRUST DRAM 77926X320 $44.5M 0.81% 603,000 SH
41 CRINETICS PHARMACEUTICALS IN CRNX 22663K107 $44.4M 0.81% 1,186,279 SH
42 CEREBRAS SYSTEMS INC CBRS 15675D103 $38.0M 0.69% 171,900 SH
43 DICKS SPORTING GOODS INC DKS 253393102 $34.3M 0.63% 151,320 SH
44 BROADCOM INC AVGO 11135F101 $31.6M 0.58% 83,600 SH
45 COMPASS THERAPEUTICS INC CMPX 20454B104 $30.9M 0.56% 14,101,159 SH
46 LEXEO THERAPEUTICS INC LXEO 52886X107 $29.7M 0.54% 6,384,200 SH
47 UNITEDHEALTH GROUP INC UNH 91324P102 $26.7M 0.49% 64,130 SH
48 PROKIDNEY CORP PROK 74291D104 $25.2M 0.46% 12,341,266 SH
49 WHITEHAWK THERAPEUTICS INC WHWK 00032Q104 $19.7M 0.36% 4,300,000 SH
50 SPACE EXPLORATION TECHN CORP SPCX 84615Q103 $17.3M 0.32% 101,200 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $5.47B 96 0001172661-26-003727
2026-03-31 2026-05-15 $3.92B 89 0001172661-26-002340
2025-12-31 2026-02-17 $4.88B 93 0001172661-26-001088
2025-09-30 2025-11-14 $3.91B 93 0001172661-25-004838
Filer Information
Address
11 E 26TH STREET
16TH FLOOR
NEW YORK, NY 10010
Phone
(212) 702-5205
Filing Manager
MONTANOVA CAPITAL, LLC
New York, NY
Signatory
Glenn Shepard
Chief Financial Officer